1CryoBio wins award at 2017 CPhI Pharma Awards

Following a successful application, 1CryoBio was among the finalists for the category “Excellence in Pharma: Analysis, Testing, and Quality Control” at the 2017 CPhI Pharma Awards. 1CryoBio is proud to win the award, prevailing against big and established companies like Merck and SGS. The results were announced at the gala of 2017 CPhI in Frankfurt […]

1CryoBio at BIOFIT 2016 in Lille

With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming from public research institutions, academic spin-offs and emerging biotech companies. 1CryoBio was […]

FlexiQuot® Labels Win Award!

Produced by and developed with the Swiss company TOVENCA AG, the innovative FlexiQuot® labels won the Innovation Award in the 35th Eruopean FINAT label competition. During development of this unique label a number of challenges had to be mastered: The materials and adhesive have to withstand temperatures of up to minus 196° over years (long-term […]

1CryoBio Selects Production Partner.

1CryoBio has entered into a collaboration with GEMÜ Switzerland for production of the patented FlexiQuot® cryotubes, the first product in 1CryoBio’s portfolio to revolutionise cryostorage. GEMÜ Switzerland develops, produces and sells high grade plastic solutions for several industries. Its products are used in medical and environmental technology, in the pharmaceutical and food industry, in biotechnology, […]

1CryoBio AG Founded And Financed.

1CryoBio AG was founded in Switzerland on February 13th, 2014, and has been entered into the Commercial Register Lucerne on February 20th, 2014. In parallel 1CryoBio closed a seed investment round from the group of founders and secured further investment from a Swiss foundation supporting start-up businesses. With this the company is well set to […]